Evidence map›Paper›PMID 42888241›Full record

ArticleBDJ open2026

Formation of hydroxyapatite on tooth surfaces by calcium hypophosphite in saliva.

Pascal Fandrich, Erik Schulze Zur Wiesche, Bennett Tochukwu Amaechi, Joachim Enax

Abstract read
PubMed Publisher
In one paragraph

Article in BDJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pascal FandrichResearch Department, Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany.ORCID http://orcid.org/0000-0002-6301-2565
Erik Schulze Zur WiescheResearch Department, Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany.
Bennett Tochukwu AmaechiDepartment of Comprehensive Dentistry, School of Dentistry, University of Texas Health San Antonio, San Antonio, TX, USA.ORCID http://orcid.org/0000-0002-5097-4466
Joachim EnaxResearch Department, Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany. joachim.enax@drwolffgroup.com.ORCID http://orcid.org/0000-0002-8334-6423

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis in vitro study aimed to investigate whether calcium hypophosphite (CaP) mediates hydroxyapatite (HAP) formation in artificial and human saliva and, in a proof-of-principle toothbrushing model, promotes mineral deposition and occlusion of dentinal tubules.

methodsA CaP solution was added to artificial saliva and human saliva, respectively. The resulting precipitate was analyzed using X-ray powder diffraction (XRD). For the toothbrushing simulations, human dentin specimens were allocated to a test group treated with 2 wt% CaP solution and a control group treated with deionized water (n = 5 per group). The specimens were immersed in artificial saliva and subjected to five consecutive 30 s brushing treatments. Confocal laser scanning microscopy (LSM) was used to assess changes in dentinal tubule occlusion before and after treatment, scanning electron microscopy (SEM) was used to examine the morphology of the deposits, and energy-dispersive X-ray spectroscopy (EDX) was used to analyze their elemental composition.

resultsIn artificial saliva and human saliva, CaP led to the formation of HAP. XRD analysis of the precipitates showed characteristic HAP peaks, with a mean crystallite size of (5.7 ± 0.6) nm and crystallographic parameters of a = (9.484 ± 0.003) Å, c = (6.868 ± 0.002) Å and V = (535.0 ± 0.4) Å

conclusionCaP mediated HAP formation in artificial and human saliva. The proof-of-concept dentin experiment demonstrated mineral deposition within open dentinal tubules. Although firm conclusions regarding efficacy cannot be drawn, these promising findings merit further exploration in properly powered studies. With further confirmatory studies, CaP has potential as a desensitizing agent for oral care formulations.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.